Chemical and Metabolic Profiling of Si-Ni Decoction Analogous Formulae by High performance Liquid Chromatography-Mass Spectrometry

Qian Chen, Shun Xiao, Zhenhao Li, Ni Ai, Xiaohui FanScientific 2015 · DOI

TL;DR

This study tackles the complexity of Traditional Chinese Medicine (TCM) by developing a systematic approach to chemically profile five related "analogous" formulas (Si-Ni decoctions) used for cardiovascular diseases. By combining advanced liquid chromatography-mass spectrometry (LC-MS) techniques, they identified a significant number of compounds in vitro and in vivo, providing a foundation for understanding how these complex herbal mixtures exert their therapeutic effects.

What Problem Does This Paper Address?

Traditional Chinese Medicine (TCM) plays a crucial role in healthcare, with its use expanding globally. TCM often employs complex formulas, which are combinations of multiple herbs designed to work synergistically. However, understanding the precise chemical composition of these formulas and how they translate into therapeutic effects is a major challenge due to their inherent complexity. This paper focuses on "analogous formulae," a specific category of TCM formulas that share common herbs or are used for similar syndromes. The authors aim to unravel the chemical profiles of these analogous formulas and investigate their metabolic fate in vivo, which is essential for elucidating their pharmacological basis and improving our understanding of TCM compatibility principles.

Methods

The core of this research lies in the application of advanced analytical techniques, primarily High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC-MS). Specifically, they employed:

  • Multistage MS and High-Resolution MS (HR-MS): These techniques allow for detailed structural elucidation of compounds by analyzing their fragmentation patterns and accurate mass-to-charge ratios. This is crucial for identifying known and potentially novel compounds within complex mixtures.
  • TCM Potential Target Database (TCM-PTD): An in-house database containing information on ingredients from traditional Chinese medicinal materials was used for initial compound identification.
  • REAXYS Database: For compounds not found in the in-house database, this comprehensive chemical database was utilized.
  • Pre-classification Strategy: This novel approach, proposed by the authors, groups compounds based on shared structural characteristics (e.g., alkaloids, flavonoids) to streamline the identification process.
  • Diagnostic Fragment-ion-Based Extension Strategy: This method leverages characteristic fragmentation patterns to identify related compounds.
  • In Vivo Analysis: After oral administration of the TCM formulas to rats, blood plasma was analyzed using LC-MS to identify absorbed prototype compounds and their metabolites.

Datasets

  • TCM Potential Target Database (TCM-PTD): An in-house database containing 12,629 ingredients from 490 traditional Chinese medicinal materials.
  • REAXYS Database: A commercial chemical database used for further compound identification.
  • Rat Plasma Samples: Collected from rats treated with the Si-Ni decoction analogous formulae.

Key Insights and Ideas

  • Analogous Formulas as a Strategic Focus: By studying analogous formulas, the researchers could leverage shared components and identification strategies to accelerate the profiling of multiple related formulas, demonstrating an efficient approach to tackling TCM complexity.
  • Systematic In Vitro and In Vivo Profiling: The study successfully combined in vitro chemical profiling of the decoctions with in vivo metabolic profiling in animal models, providing a comprehensive view of both the initial composition and the fate of these compounds in the body.
  • Identification of Diverse Compound Classes: The research identified a broad range of bioactive compounds, including alkaloids, flavonoids, ginsenosides, bile acids, and triterpenoids, highlighting the rich chemical diversity within these TCM formulas.
  • Metabolites as Key to Efficacy: The detection of numerous metabolites in rat plasma suggests that biotransformation plays a significant role in the pharmacological activity of these TCM formulas, emphasizing the importance of considering metabolic pathways.

Key Results

  • 83 Compounds Identified In Vitro: The study identified a total of 83 compounds across the five Si-Ni decoction analogous formulae.
  • 55 Prototype Compounds Absorbed In Vivo: Analysis of rat plasma revealed that 55 prototype compounds from the decoctions were absorbed into the systemic circulation.
  • 39 Metabolites Detected In Vivo: In addition to prototype compounds, 39 metabolites were identified in the rat plasma, indicating significant biotransformation.
  • Method Validation: The developed HPLC-MS method demonstrated satisfactory repeatability, stability, and precision, making it reliable for qualitative analysis.
  • Identification of Specific Compounds: The paper details the identification of specific alkaloids (e.g., 14-hydroxy-2-isobutyrylhetisine N-oxide), flavonoids (e.g., schaftoside), and triterpenoids (e.g., Licorice saponin A3), providing concrete examples of the identified constituents.

Limitations and Future Work

  • Quantification of Absorbed Compounds: While the study identified absorbed compounds and metabolites, it acknowledges the need for further work to quantify these components and their relative concentrations.
  • Functional Studies: The paper suggests that future research should focus on quantifying absorbed compounds and investigating how they regulate biological processes to fully understand the pharmacological mechanisms.
  • Clinical Relevance: While the study provides a strong foundation, further research is needed to directly link these chemical and metabolic profiles to the clinical efficacy of the Si-Ni decoction analogous formulae.
  • Broader Analogous Formulae: The study focused on five specific Si-Ni decoctions; future work could expand this approach to other categories of analogous TCM formulas.

Summary updated

Abstract

Along with an indispensable role in healthcare system of China for centuries, Traditional Chinese Medicine (TCM) shows increasing usages as complementary therapy in western countries. To improve our understanding on their therapeutic effects, it's critical to unveil chemical compositions of TCM formula, the predominant form of therapy in TCM. However, intrinsic chemical complexity makes it a challenging task to perform analysis on each individual TCM formula even with most current state-of-art analytic techniques available. In this work we approached this question by focusing on analogous formulae, a unique category of TCM formulae grouped together based on shared herbs and/or similar TCM syndromes. Systematic chemical profiling on five Si-Ni decoctions (SNs) for cardiovascular diseases was performed by multistage MS and high-resolution MS (HR-MS) experiments. A total of 83 compounds, including alkaloids, flavonoids, ginsenosides, bile acids and triterpenoids, were described. Analysis on SNs-treated rats detected 55 prototype compounds and 39 metabolites in the systemic circulation in vivo, which may contribute directly to their observed clinical efficacies. This approach offers great advantage to speed up identification of chemical compositions of formula and reveal the difference among these analogous formulae that may be related to diverse clinical effects.
BibTeX
@inproceedings{chen2015chemical,
  author = {Qian Chen and Shun Xiao and Zhenhao Li and Ni Ai and Xiaohui Fan},
  title = {{Chemical and Metabolic Profiling of Si-Ni Decoction Analogous Formulae by High performance Liquid Chromatography-Mass Spectrometry}},
  booktitle = {Scientific},
  year = {2015},
  doi = {10.1038/srep11638},
}
Figure